WO2004108947A2 - Traitement du terrain biologique - Google Patents

Traitement du terrain biologique Download PDF

Info

Publication number
WO2004108947A2
WO2004108947A2 PCT/US2004/017316 US2004017316W WO2004108947A2 WO 2004108947 A2 WO2004108947 A2 WO 2004108947A2 US 2004017316 W US2004017316 W US 2004017316W WO 2004108947 A2 WO2004108947 A2 WO 2004108947A2
Authority
WO
WIPO (PCT)
Prior art keywords
dno
dyes
values
patient
terrain
Prior art date
Application number
PCT/US2004/017316
Other languages
English (en)
Other versions
WO2004108947A3 (fr
Inventor
Timothy Nicholas Ray
Original Assignee
Bioray Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioray Inc. filed Critical Bioray Inc.
Publication of WO2004108947A2 publication Critical patent/WO2004108947A2/fr
Publication of WO2004108947A3 publication Critical patent/WO2004108947A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/411—Detecting or monitoring allergy or intolerance reactions to an allergenic agent or substance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/415—Evaluating particular organs or parts of the immune or lymphatic systems the glands, e.g. tonsils, adenoids or thymus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4854—Diagnosis based on concepts of traditional oriental medicine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A61B10/0051—Devices for taking samples of body liquids for taking saliva or sputum samples
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B10/00—Other methods or instruments for diagnosis, e.g. instruments for taking a cell sample, for biopsy, for vaccination diagnosis; Sex determination; Ovulation-period determination; Throat striking implements
    • A61B10/0045—Devices for taking samples of body liquids
    • A61B10/007—Devices for taking samples of body liquids for taking urine samples
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/41—Detecting, measuring or recording for evaluating the immune or lymphatic systems
    • A61B5/414—Evaluating particular organs or parts of the immune or lymphatic systems
    • A61B5/416—Evaluating particular organs or parts of the immune or lymphatic systems the spleen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/45—For evaluating or diagnosing the musculoskeletal system or teeth
    • A61B5/4538—Evaluating a particular part of the muscoloskeletal system or a particular medical condition
    • A61B5/4542—Evaluating the mouth, e.g. the jaw
    • A61B5/4547—Evaluating teeth

Definitions

  • the present invention is directed to a method of measuring, evaluating and regulating the state, flow and function of bioelectrical energy in the body and mind, referred to as the terrain.
  • the bioelectrical inner environment of the human body is sometimes referred to as the "terrain".
  • the terrain includes the cells comprising the body, organs, and the interface between energy and body tissue.
  • the integrity of the terrain is the factor that determines why one person will get food poisoning and another will not - from the same infected meal. It is very difficult for a disease to live in a balanced terrain. Therefore, a person having a relatively balanced terrain will typically have good health and well-being.
  • the 'terrain is everything' and the pathogen is everything.
  • the terrain can be perfect, but pollute it with Ebola, methyl mercury or radiation and you are still in trouble. Remove the Ebola, methyl mercury or radiation without restoring the terrain, and you are still in trouble.
  • the biochemist Carrey Reams devised a method of analyzing saliva pH, as well as urine pH, urine conductivity, urine sugars/brix, urine NH4+, and urine NO3- to measure the electrical and ionization effects of foods, supplements and therapies on the bioelectrical properties of the human system.
  • Prior methods focused only on removal of a particular pathogen being ingested (or absorbed) in the terrain, but failed to address restoration of the terrain as well as ingestion. Specifically, saliva properties (aside from pH) were not considered. The distinction between an intervention that has exclusively beneficial effects and one that also produces harm is whether it simultaneously addresses the pathogen as well as the terrain.
  • the present invention is directed to a system and method for applying Real-Time Functional Medicine that includes restoration of the terrain in the treatment of acute and chronic conditions.
  • Figure 1 shows a panel having fields for property data from saliva and urine
  • Figure 2 is a table of formulas for calculating property values according to the present invention
  • Figure 3 is a first console page displaying data according to the present invention
  • Figure 4 is a second console page displaying data according to the present invention.
  • Figure 5 is a spreadsheet page displaying data input fields according to the present invention. Summary Of The Invention
  • the present invention is directed to an objective method of assessing and regulating the state, flow and function of bioelectrical energy in the body and mind, referred to as the terrain.
  • the study and assessment of human structure and function i.e. the terrain
  • biological terrain management (“BTM")
  • BTM biological terrain management
  • the needs of a particular patient are determined. Treatment of the patient may be focused based on the specific determined needs as well as the patient's specific terrain, thereby optimizing utilization of the supplied needs.
  • the method of the present invention is applicable to the removal of obstacles (as discussed in detail below), the restoration of metabolic, mental, and emotional efficiency, and therapeutic interventions.
  • One skilled in the art is able to determine if the patient is able to utilize what they need, and if not, look for solutions to restore their ability to respond. As the patient is moved closer to Zero Need, regulation opens. Zero Need indicates that all properties of a person's urine and saliva are normal. Arriving at Zero Need does not indicate that the person is 'cured'. It means that the terrain is again functional and no longer a host for disease.
  • the patient is maintained at Zero Need for a period of time sufficient to restore 'self-regulation' to the patient, which allows the Inner Healer to function once more. This is an extremely powerful place within which interventions are much more effective and occasionally unnecessary. The process of self- regulation is many times a prerequisite for the successful treatment of many conditions.
  • the present invention takes into account our increasing toxicological challenges, and allows the study and evaluation of multiple terrain reactions rather than isolated states. In this way, a valuable and timely clinical method of understanding and fulfilling patient needs is provided.
  • This approach of the present invention allows equal importance to the terrain and the pathogen, providing an objective evaluation of a patient's needs while determining the effectiveness of any interventions. Further, a method of supporting the terrain if and when a patient requires an intervention is provided that is safe and optimal for the patient.
  • the system and method of the present invention does not diagnose or treat disease; instead it evaluates and enhances the structure and function of the terrain with Real-Time Functional Medicine.
  • the system and method of the present invention is based on the relationships and needs of anions vs. cations, positive ions vs. negative ions, and alkalinity vs. acidity in the terrain. These relationships may be calculated from measurements taken from samples of saliva and urine from a patient. Specifically, the following properties of a saliva sample may be determined using conventional techniques known in the art: pH (acidity or alkalinity), mS (conductivity), Brix (sugar content), NO3 (nitrate), and NO4 (ammonium). Likewise, the same properties of a urine sample may be determined using conventional techniques known in the art.
  • the resulting values for the relationships define a collection of information about the patient's terrain and needs. This collection of information is defined herein as a "zone". Treatment may then be assessed and provided in light of the patient's deviation away from "normal relationship values". In addition, the impact of particular foods, medicine or therapy on each of the values may be determined based on the particular zone in which the patient's relationship values fall.
  • Appropriate treatments may then be selected which cancel out any negative vectors, thereby restoring the terrain to normal metabolism. Once that balance is achieved (regulation is opened), the inner healer comes back to work and the person can again respond to therapy.
  • a terrain graph plots values derived from urine and saliva samples, including values for the redox potential, the acidity and/or alkalinity, the presence of positive and/or negative ions, and the conductivity: a b c
  • a-f redox potential
  • i-e urine pH
  • b-e plotted point derived from i-b and i-e.
  • f-c cationic, anionic
  • the system and method of the present invention is designed to help the health professional see, understand and manage shifts in the terrain during therapy.
  • the system and method of the present invention provides options for terrain support and evaluation of the effectiveness of the options.
  • the present invention further shows the impact of a medicine or therapy (i.e. an intervention) on the terrain, and then allows for compensation or amplification of any effects such an interventional may have on the patient.
  • a medicine or therapy i.e. an intervention
  • using the system and method of the present invention can determine if the 'cure' is killing the patient, mitigate the adverse effects, objectively evaluate progress, quickly signal a patient's changing needs, thus allowing the patient to get the benefit of the therapy. It can also be used for prevention by developing nutritional programs that best serve the individual terrain.
  • An exemplary questionnaire for identifying such obstacles is set forth at Appendix I.
  • the questionnaire is also provided at www.healthydetox.org, identified therein as the Ladder to Freedom Questionnaire. Once the questions are answered by a patient, the resulting data is assessed, and a target "Ladder to Freedom" (provided in Appendix I) is generated based on his or her responses.
  • the Ladder indicates the first obstacle that should be addressed at the bottom of the column of obstacles. Once the first obstacle has been overcome, the next obstacle up from the bottom is addressed, and so forth.
  • Diet can be and usually is a major Obstacle to progress. Also provided on my website at www.healthvdetox.org is the document 'Common Sense Health' that offers some practical guidelines as to how to discover a person optimal diet.
  • the first step to an optimal diet for most individuals is to remove acid forming foods, and replace them with alkaline forming diet appropriate to an individual's blood type.
  • An alkaline forming mineral supplement may provide benefit as well.
  • the basic process to an optimal diet is: 1) Learn Common Sense Principles regarding food, water, exercise, sleep and fun; 2) Identify the obstacles to good health that pertain to you and remove them; 3) Remove the toxins generated by those obstacles; and 4) Repair the damage.
  • Type O. Wheat dairy, cabbage, nightshades, pickled or fermented foods.
  • Type A Corn, tomatoes, peanuts, sesame, cayenne, and red meat.
  • Type AB Corn, chicken, orange, salt, pepper, vinegar.
  • Type B Chicken, corn, nuts & seeds, tomato. If you have any symptoms of bloating, abdominal discomfort, gas, or feel tired after food, avoid all sweets. Sweets include anything that tastes sweet, no exceptions. This is temporary until your gastro intestinal tract has returned to normal function. How to Eat
  • Homeopathic remedies can be made by consecutively diluting a substance in it and 'succussing' or shaking it. None of the substance eventually remains but its frequency locks into the outer electrons of the water molecules.
  • the solution is to put a pair of powerful north pole magnets around the incoming water pipe after the ground point. This degausses the water and improves taste.
  • the catabolic cycle runs from 3 a.m. to 3 p.m. (time to detox, function) and the anabolic cycle starts at 3 p.m. and runs to 3 a.m. (time to rest and rejuvenate). Lack of rest will create disease and disease will create inability to rest.
  • the present invention is further directed to a novel software data management application and graphical and numerical representation of that data, that accepts standard and non standard chemistry values determined from a person's urine and saliva, analyzes them as to bioelectrical nature, represents them in a unique and new way both graphically and numerically, gives observations of foods, supplements and therapies with similar and opposite characteristics, and further tracks the bioelectrical correlation of the observations with pre and post consumption measurements of the person's urine and saliva.
  • These results of pre and post testing are accepted into a database, divided into files of single substances, and then further analyzed for statistical significance and percentage of effectiveness.
  • This software is offered as a 'pay per test' website application. This program is not intended to diagnose, mitigate, treat or cure any disease.
  • the software program has a novel and unobvious representation of data including layout, data input screen, graphic representations of data, the flow of the program, numerical portrayals of data, user interface design, console design, file and data management design, data analysis method, instructional explanatory and tutorial text, and interpretations of relationships between the data.
  • the Values, Ratios And Needs are novel and unobvious representations of data including layout, data input screen, graphic representations of data, the flow of the program, numerical portrayals of data, user interface design, console design, file and data management design, data analysis method, instructional explanatory and tutorial text, and interpretations of relationships between the data.
  • One aspect of the present invention is the ability for one skilled in the art to see, understand and use the bioelectrical effect of foods, remedies and therapeutic interventions, through their calculated values, on the terrain.
  • the present invention utilizes remedies and foods and therapies to restore the terrain to balance, not only because of their nutrient or ingredient value, but because of their bioelectrical impact on the terrain as expressed by cationic vs. anionic, positive ion vs. negative ion, acid vs. alkaline, and Redox needs and state. This is a very different way of looking at foods and remedies and therapies. We all need potassium, for example, but some people do well with the citrate form, others with orotate, and others with the chloride.
  • the system and method of the present invention allows one skilled in the art to determine for each patient which is the best form of potassium to administer, evaluate the impact of that form on the patient, and therefore to adjust the dosage for the optimal or desired effect.
  • the present invention makes sense out of why chocolate is of benefit for one person and a poison for the next.
  • the present invention gives you a way of seeing the exact impact of any ingestion or intervention on the terrain with pre and post Panels. As you will see, this applies to differentiating between the various cancer therapies, support for dental extractions, detox and diet protocols, remedies and the like.
  • Quadrant values according to an embodiment of the present invention are provided in the graph shown in Table II below. Each quadrant enumerates obstacles to be avoided.
  • the value plotted on the Quadrants is corrected according to this chart because what we are monitoring is the body's need or inability to mount the alkaline reserve.
  • the urine pH tells us if the acids of normal metabolism and other toxins are able to get out of the body, therefore it needs to stay on the acid side. If the urine is too alkaline and the salts value is too low, you will see weakness in the liver and disturbances in the Phase 1 & 2 liver detoxification pathways.
  • the needs are cationic and negative. Therefore the effect of raising the salts value is to provide a positive and anionic reaction.
  • the needs are now anionic and positive, therefore the effect of lowering the salts value is to provide the opposite, a cationic and negative reaction.
  • Normal sugars is a Brix of 4. If the sugar value is below normal one could assume that the adrenals were weak, or the pancreas was over stimulated, or that there might be increased insulin sensitivity or, there could be something causing stress on the adrenals, like a scar or tooth problem on the associated meridian, or acid irritation from excess protein consumption. If the sugar value is too high one might think that the pancreas was under producing insulin, or that the pH surrounding the pancreas was too acidic, or that there might be an adhesion affecting its performance, a nutritional deficiency or a combination of the above. So you do a lab test and discover that they are chromium deficient. You give them chromium and they may or may not be able to utilize it. However, if you restore the terrain, the sugars will return to normal and they will be able to get all the chromium they need from their food.
  • NH4 Normal-NH4 is 6.5.
  • the need For values greater than normal, the need is anionic and negative. The state is cationic and positive. For values less than normal, the need is cationic positive, the state is anionic positive.
  • Example 1 Samples of saliva and urine are taken from a patient, and properties identified above are calculated using methods known in the art.
  • the resulting properties for saliva and urine include pH, mS, Brix, N03 and N04. As best shown in Figure 1, these properties may be input into fields in a computer program.
  • the computer program then calculates relationship values for saliva and urine using calculations set forth in Figure 2. Specifically, the following values are provided for both urine and saliva: anion (AN) vs. cation (CAT), positive ions (P) vs. negative ions (N), and alkalinity (AL) vs. acidity (AC) in the terrain. Equations for calculating these relationships is well known in the art, such as explained by Alexander Beddoe, D.D.S.
  • tne specific zone in which the patient falls may be determined using the Tables of Needs, as provided in Table IV below.
  • the Table of Needs includes twelve zones. Each zone is defined by a combination of values indicating either anion (AN) or cation (CAT), positive ion (P) or negative ion (N), and alkaline (AL) or acidic AC).
  • each zone specifies what treatment may be required to alleviate the greatest imbalance. For example, Zone 1 below indicates a treatment focusing on alkalizing saliva (i.e. if patient saliva is highly acidic).
  • the Table of Needs identifies the major imbalance.
  • the arrow pointing up shows the organ that needs to be strengthened.
  • the kidney needs to be strengthened in Zone 10.
  • the arrow pointing down shows the organ that requires drainage: heart, blood, endocrine.
  • "Lower NH4" shows you the primary goal. Q4 tells you they need substances from Quadrant 4, and to move in that direction. The substances or therapies listed let you know major Intervention Strategies for this zone.
  • the lower case letters (m,d,l) next to the firing order lets you know if they are in mid, light or dark RED. In this case it is dark red because the AN need is first. There ape specific foods to use and avoid for each determination in each Color Zone, or 36 different base diets.
  • the relationship values may be used to calculate the bodies ability to experience ' cationic and anionic events, the ionization potential required to do so as either positive or negative ions, the oxidation reduction effect resulting from this process and incoming pollutants, and their combined effect on the acid base balance and buffering capability of the system.
  • This transformative ability is dependant on the integrity of the electrodynamic field that maintains the organization of the system, an imbalance in which can be observed as abnormalities in the proportional relationship of the normal values. This is why exposure to certain powerful electromagnetic fields and frequencies, radiation, microwaves, geopathic stress, and battery effects and their fields in human chemistry all cause a scientifically proven shut down of the immune system and various forms of disease. It is the electromagnetic impact of the toxin on this electrodynamic field that concerns us.
  • Table VI includes treatment information corresponding to Zones Z5-Z6 and Z12a
  • Table VTJ includes treatment information corresponding to Zones Z7-Z9a Table VII:
  • Table XDI includes treatment information corresponding to Zones Z9b and ZIO.
  • Table XIH includes treatment information corresponding to Zones Z9b and ZIO.
  • Table DC includes treatment information corresponding to Zones Zl 1 and Z12b.
  • Table IX Table IX:
  • Treatment information provided in one zone may also be cross-referenced with treatment information provided in another zone, given some of the relationship values overlap. As such, some of the permissible treatments overlap, as shown below in Tables X, XU, XV, and XVTf. Treatment information for zones Z4, Z7, Z6 and Z2 is provided above, as well as in tables XI, XIJJ, XTV, and XVI below. Table X:
  • Zone Tables may then be correlated to the Saliva Reference Values ("SRV”) Basic Support Table, as set forth below in Table XVTfl.
  • SSV Saliva Reference Values
  • the SRV Basic Support Table may be used if a particular patient's saliva properties are further from normal balance compared to urine properties. Preferably, if saliva properties deviate from normal more than 10% greater than the deviation of urine from normal, the above SRV Basic Support Table is used for determining the primary strategy.
  • Zone Tables may also be correlated to the Urine Locator Value ("ULV") ratios set forth in the ULV Ratios Basic Support Table shown in Table XLX below: Table XTX:
  • ULV Urine Locator Value
  • the ULV Ratios Basic Support Table may be used if a particular patient's ratio properties are further from normal balance compared to urine properties.
  • the console page shown in Figure 3 includes relatively imbalanced urine properties, shown in Biogram 2 (10).
  • the patient also displays imbalanced saliva properties, shown in Biogram 1 (12), though not as deviant as Biogram 2.
  • Psyche deviation (14) is also provided on the console page. Note that the greatest deviation indicates urine pH is -100.0% off from normal (16).
  • the primary strategy (18) includes raising urine pH.
  • Treatment is provided in the Zones Table for Zone 9b, Table XUJ (given CAT need is less than AN need), and indicates a treatment comprising a blood cleanser and/or lymph drainage.
  • the console page shown in Figure 4 includes relatively imbalanced saliva properties, shown in Biogram 1 (20). The patient displays only slightly imbalanced urine properties, shown in Biogram 1 (22).
  • the SRV Basic Support Table, Table XVUI may be consulted for treatment options.
  • the Zone Tables may be used, in which case the individual falls within Zone Z10, with a urine pH deviation of 51%.
  • Data provided in the console pages is calculated using methods disclosed herein, and as provided in calculations set forth in Figure 2. This data may then be input into a spreadsheet program to create the biograms (i.e. data plots) provided on the console pages, such as shown in Figures 3-4.
  • An exemplary format for the spreadsheet program is provided in Figure 5.
  • Specific treatment is thus provided according to the Zones Tables.
  • Specific foods that are beneficial to a particular patient (depending on the Zone in which he or she falls), as well as foods that should be avoided, are set forth in Appendix U.
  • the information provided in Appendix II may be used to enhance treatment of the particular treatment administered to a patient.
  • the bioelectrical state and needs of the body can be determined from urine and saliva pH and ORP, and urine conductivity, sugars (brix), NH4+, and N03-, which are then calculated to represent anionic / cationic, positive ion / negative ion, acid / base, and oxidation / reduction state and need. Calculations of these relationships provide the following data:
  • Quadrant 1 Anionic states correlate to Quadrant 1, and may be graphically represented as such on the f-c axis; 3. Positive and negative ion may be calculated from conductivity, brix, NH4+ and N03-, graphically represented on the a-h axis, and remain consistent with the findings of both Vincent and Reams; 4. Quadrant 3 did not represent 'alkalinity', but an alkaline reaction to an acidic state of the tissue, likewise Quadrant 1, an acidic reaction to an alkaline substance. Tissue acidity is a fundamental finding in pathology in Biological Medicine.
  • a patients' values may be plotted onto the Quadrants.
  • the darker gray triangle shows their state, and the lighter gray triangle shows their need.
  • the dot represents the corrected pH values as described above.
  • the second view represents the calculated values and is called the 'Window of Opportunity', which calculates the difference between the two and reveals dosage sensitivity and specificity. Following are examples of : 1) A mild liver drainage disturbance.
  • the "i” point, or center of the graph, represents point zero, or "Zero Need” - the goal.
  • Interventions are prioritized according to the most relevant need.
  • Interventions can be assessed and logged per their specific effects on specific values.
  • BTM allows you to evaluate the terrain, know when to provide support, how to provide support, and then evaluate the effectiveness of the support relevant to utilization of the intervention.
  • Heavy Metal toxicity is a 'Pathogen' from which the terrain cannot generally recover on its own. It produces a rigid cationic. positive, oxidized, and acidic terrain state. This state frequently triangulates up into Quadrants 3 and sometimes 2.
  • Pharmaceutically altered sulfur compounds like DMPS, a sulfonate, and chemicals such as EDTA and DMSA also have a cationic, positive, and acid effect on the terrain and triangulate into Quadrant 3.
  • the substances in a Quadrant generate the imbalances found in the same Quadrant, whereas substances in the opposite Quadrant pull the terrain towards Zero Need. Therefore, these chemical methods of detox (in Quadrant 3) are directly contraindicated for metal toxic persons who triangulate into Quadrant 3. This explains a terrain specific aspect of the
  • NDF a natural heavy metal and chemical detoxification agent invented by this author
  • NDF has a flexible anionic, negative and positive, and alkalizing effect on the terrain. It triangulates into the opposite Quadrant 1, which is directly indicated. This is another reason why a 'healing crisis' is either minimized or not required during metal and chemical detox with NDF.
  • NDF tends to mitigate some of the side effects associated with DMPS and DMSA: it's a bioelectrical balancing phenomena due to NDF's anionic impact offsetting the cationic impact of both the chemical chelators and the heavy metals.
  • the urine represents what we are eliminating; the saliva represents what we are keeping.
  • the urine does not accurately represent the state of the body, but does represent what it is eliminating - ideally acidic wastes.
  • the first morning saliva pH is the indicator of the state of the body: tissue, lymph, interstitial fluids and blood.
  • normal urine pH is about 5.8; normal saliva pH is about 7.1 am not suggesting that one acidify the body by acidifying the urine, but that one alkalizes the body by draining the acids via the urine, represented by an acidic urine pH, and simultaneously restoring the alkaline reserve as represented by the saliva pH at 7.
  • tissue acidity (free radicals, lactic and oxalic acid, etc. causing lack of oxygen) is a cause of pain and fatigue, but may not be the only cause. If the situation is complicated by viral, bacterial, parasitic and allergic causes, the tissue acidity caused by heavy metal toxicity will block the successful elimination of these other more superficial causes.
  • the protocol options are selected according to their simultaneous impact of fulfilling the specific needs and correcting Regulation within the context of Zone 5.
  • Exercise mild walking
  • Hatha Yoga Therapy Negativeur or Grounding
  • check for amalgams in teeth check for EMR exposure
  • check for adhesions in the URQ gall bladder and liver area
  • check for focal scars on the GB and Sp meridians local biophoton therapy.
  • IIO2 Inhaled Ionized Oxygen Therapy: 10 minutes positive, 2 minutes negative
  • Diet Lemon, pineapple, beet. Print Diet list. Contraindications: sulfones, hydrocarbons, vigorous exercise in the sun, heat, hyperthermia, chlorine/bromine/fluorine exposure, EMR exposure, ozone, excess water. See Diet List. Dosage: Ramp up in 25% increments. follow up: Retest in 3 days.
  • this category of recommendation addresses the most out of balance value with a single remedy intervention. This way of approaching the case allows for one correction at a time, and then reevaluating its impact on the terrain. In this case it would be to drain acids and raise urine conductivity for a few days and then reevaluate the situation. LiverLifeTM also happens to provide an excellent preparation for detox. This single intervention, restoring the ability to eliminate acids, can have profound effects on the rest of the terrain.
  • the BTM software generates the above information and more, including graphs representing the numerical values. Tables containing further intervention suggestions are available so the practitioner can select items that may be more pertinent to the patient's symptoms and still pertinent to the needs of the terrain.
  • BTM is a completely objective method of measuring, evaluating and regulating the state, flow and function of bioelectrical energy in the body and mind, referred to as the terrain.
  • BTM we are finding out what someone needs and then giving it to them in a way that they can utilize it and in the order required. This applies to the removal of Obstacles, the restoration of metabolic, mental, and emotional efficiency, and therapeutic interventions.
  • As we move them closer to Zero Need regulation opens. Arriving at Zero Need does not indicate that the person is 'cured'. It means that the terrain is again functional and no longer a host for disease. We have to keep them there long enough that 'self-regulation' is restored, which is similar to saying that the Inner Healer can function once more. This is an extremely powerful place within which interventions are much more effective and occasionally unnecessary.
  • the BTM method of the present invention includes analyzing specific properties of a patient's saliva and urine using laboratory techniques know in the art. Relationship values are thereby determined from the property data, and the zone in which the patient falls is established. Once the zone has been determined, the primary strategy (i.e. particular treatment) may be determined based on the Zone Tables. However, the specific treatment may be altered depending on the patient's saliva and urine deviations (from normal values, as known in the art), as well as ratio values, as provided in the SRV Basic Support Table as well as the ULV Basic Support Table.
  • the patient's data is preferable plotted on a terrain graph using data for both urine as well as saliva. All of this information may then be presented and managed on a console page as disclosed herein.
  • various obstacles specific to his or her quadrant should be avoided, as set forth in Table H
  • plotting the data on a terrain graph helps to identify the obstacles to be avoided.
  • the patient should not ingest foods that will negate, or hamper, the benefits or the treatment provided in the primary strategy.
  • particular foods are beneficial and other foods should be avoided. Such foods are set forth, by zone, in Appendix II. Thus, adherence to beneficial foods, and avoidance of deleterious foods, helps to ensure that the patient receives the maximal benefit of the primary strategy.
  • Section 1 Acute Conditions 1) Do you have an acute infection or fever above 101 degrees F? Dyes Dno
  • Dyes Dno D not applicable 31 Have you ever had a full course of deep tissue work? If you do not know what deep tissue work is, the answer is probably no. Dyes ,• Dno 32) Were you ever injured in an accident and feel that the injury never fully healed? Dyes Dno D not applicable
  • Type O avoid dairy and wheat.
  • Type A avoid red meat, corn, tomato.
  • Type AB avoid red meat, corn, tomato, chicken, nuts & seeds.
  • Type B avoid chicken, nuts & seeds.
  • Section 8 Water Quality 55) Do you drink or cook with tap water (including water, ice, tea, and coffee in restaurants)?
  • Section 9 Household Mold & Mildew
  • Section 16 Parasitic Infections 117) Have you ever done a multiple specimen, purged stool exam for parasites?
  • Section 17 Focal Infections: virus, bacteria, & fungi
  • D don't know 130 Have you regularly eaten any of the following foods for more than 5 years? Stored grains, hulled nuts and seeds, com, peanuts, cashews, grain fed animals, antibiotic fed animals and their byproducts, cereals, bread, cheese, white sugar, alcohol, mushrooms, left over foods, yeast, com sweeteners, all seed oils, cured meats, turkey, dried fish, canned foods, bacon, lunch meats, wheat and com flour, pasta, smoked salmon. Dyes Dno D don't know
  • Section 20 Possession / Exorcism 133) Do you experience yourself behaving in ways that are clearly 'not you', or feel strange migrating sensations in your body
  • Section 22 Neurological Damage Brain Repair
  • the basic Obstacles are listed on The Ladder to Freedom in the order that they tend to be priorities to a person's health. However, each person has his or her own priorities and the following exact order may not pertain to you. The more severe the area of disturbance, the higher the priority it has.

Abstract

La présente invention concerne une méthode d'équilibrage de la structure et du fonctionnement du terrain chez un être humain. Un échantillon d'urine et un échantillon de salive sont prélevés chez un patient. Les propriétés de chacun des échantillons sont identifiées. Plusieurs zones sont définies, chaque zone définissant une combinaison de valeurs et un traitement recommandé fondé sur la combinaison de valeurs. Les valeurs d'échantillons pour le patient sont calculées sur la base des propriétés identifiées. Une des zones ayant la combinaison de valeurs est identifiée comme correspondant aux valeurs d'échantillon. Le traitement recommandé pour le patient est ensuite identifié sur la base de la zone identifiée.
PCT/US2004/017316 2003-06-02 2004-06-02 Traitement du terrain biologique WO2004108947A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US47459303P 2003-06-02 2003-06-02
US60/474,593 2003-06-02

Publications (2)

Publication Number Publication Date
WO2004108947A2 true WO2004108947A2 (fr) 2004-12-16
WO2004108947A3 WO2004108947A3 (fr) 2006-04-13

Family

ID=33511615

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2004/017316 WO2004108947A2 (fr) 2003-06-02 2004-06-02 Traitement du terrain biologique

Country Status (1)

Country Link
WO (1) WO2004108947A2 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108841476A (zh) * 2018-06-22 2018-11-20 江南大学 一种发酵型花香梨酒及其制备方法

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6152887A (en) * 1998-02-27 2000-11-28 Blume; Richard Stephen Method and test kit for oral sampling and diagnosis
US20010023324A1 (en) * 1997-11-03 2001-09-20 Allan Pronovost Glucose detector and method for diagnosing diabetes
US20040122790A1 (en) * 2002-12-18 2004-06-24 Walker Matthew J. Computer-assisted data processing system and method incorporating automated learning
US6835545B2 (en) * 2000-05-08 2004-12-28 President And Fellows Of Harvard College Methods, products and treatments for diabetes

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20010023324A1 (en) * 1997-11-03 2001-09-20 Allan Pronovost Glucose detector and method for diagnosing diabetes
US6152887A (en) * 1998-02-27 2000-11-28 Blume; Richard Stephen Method and test kit for oral sampling and diagnosis
US6835545B2 (en) * 2000-05-08 2004-12-28 President And Fellows Of Harvard College Methods, products and treatments for diabetes
US20040122790A1 (en) * 2002-12-18 2004-06-24 Walker Matthew J. Computer-assisted data processing system and method incorporating automated learning

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108841476A (zh) * 2018-06-22 2018-11-20 江南大学 一种发酵型花香梨酒及其制备方法

Also Published As

Publication number Publication date
WO2004108947A3 (fr) 2006-04-13

Similar Documents

Publication Publication Date Title
Nambudripad NAET Guidebook: The Companion to" Say Good-bye to Illness"
Gorzelak et al. Lifestyle and health
WO2004108947A2 (fr) Traitement du terrain biologique
RU2525007C1 (ru) Способ коррекции ожирения абдоминального типа
Jacobs et al. Beat Candida through Diet: A Complete Dietary Programme for Suffers of Candidiasis
Bacon Chemosensation to enhance nutritional intake in cancer patients
Tick Holistic Pain Relief: Dr. Tick's Breakthrough Strategies to Manage and Eliminate Pain
Guerrero In Balance for Life: Understanding and Maximizing Your Body's pH Factor
Haas et al. The New Detox Diet: The Complete Guide for Lifelong Vitality with Recipes, Menus, and Detox Plans
Christensen The Lyme Disease 30-Day Meal Plan: Healthy Recipes and Lifestyle Tips to Ease Symptoms
Tatta Heal your pain now: The revolutionary program to reset your brain and body for a pain-free life
Hopkins et al. Durga, J., van Boxtel, M., PJ, Schouten, EG, Kok, FJ, Jolles, J., Katan, MB and Verhoef, P.(2007) Articles: Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. The Lancet, 369, 208-216. Folstein, MF, Folstein, SE and McHugh, PR (1975)" Mini-mental state". A practical
Weeks Make Yourself Better: A Practical Guide to Restoring Your Body's Wellbeing Through Ancient Medicine
Kumar An ayurvedic perspective on food safety
Tait Your Health, Your Vitality, Your Choice: An Interlude with an Esoteric Herbalist
Govender Analysis of the nutritional status and dietary intake data of a group of elderly at a day and frail care centre in Verulam
Rubin et al. The Great Physician's RX for High Blood Pressure
Misra Journal of Vaccines & Vaccination
Gittleman Radical Longevity: The Powerful Plan to Sharpen Your Brain, Strengthen Your Body, and Reverse the Symptoms of Aging
CHARGE Obesity is a Disease: Why, and Why it Matters
Month Get the Most Nutrition from Your Calories and'Enjoy the Taste of Eating Right'during National Nutrition Month® and Beyond
Sharma Live Longer, Live Younger: The 10-step Programme to Healthy Ageing
Clark The holistic nursing approach to chronic disease
Bajaj et al. Differences in Cardiovascular Gender Based Trends in Canada
Erickson The Allure of Healing Nature: Examining the Influence of Light and Human Microbiota on Mental Health

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase